tiprankstipranks
Virpax Pharmaceuticals (VRPX)
OTHER OTC:VRPX
US Market
VRPX
Virpax Pharmaceuticals
RESEARCH TOOLSreports
Want to see VRPX full AI Analyst Report?

Virpax Pharmaceuticals (VRPX) Income Statement

215 Followers

Virpax Pharmaceuticals Income Statement

Last quarter (Q4 2024), Virpax Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Virpax Pharmaceuticals's net income was $-3.39M. See Virpax Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Mar 22Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 12.08M$ 15.69M$ 21.85M$ 12.03M$ 4.20M
Depreciation and Amortization
$ 0.00$ 500.28K$ 18.35M$ 12.03M$ 4.20M
EBITDA
$ -11.96M$ -14.69M$ 0.00$ 0.00$ 4.00K
Operating Income
$ -12.08M$ -15.69M$ -21.85M$ -12.03M$ -4.20M
Other Income/Expenses
$ 12.71K$ 500.28K$ 194.41K$ -30.56K$ -143.93K
Pretax Income
$ -12.07M$ -15.19M$ -21.65M$ -12.06M$ -4.34M
Net Income
$ -12.07M$ -15.19M$ -21.46M$ -12.15M$ -4.49M
Per Share Metrics
Basic EPS
$ -70.91$ -12.97$ -18.32$ -10.37$ -9.07
Diluted EPS
$ -70.91$ -12.97$ -18.32$ -10.37$ -9.07
Weighted Average Shares Outstanding
 4.25M 1.17M 1.17M 1.17M 494.51K
Weighted Average Shares Outstanding (Diluted)
 4.25M 1.17M 1.17M 1.17M 494.51K
Currency in USD

Virpax Pharmaceuticals Earnings and Revenue History